Ashio Yoshimura

4.4k total citations · 1 hit paper
75 papers, 2.7k citations indexed

About

Ashio Yoshimura is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ashio Yoshimura has authored 75 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Nephrology, 13 papers in Molecular Biology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Ashio Yoshimura's work include Renal Diseases and Glomerulopathies (30 papers), Chronic Kidney Disease and Diabetes (20 papers) and Autoimmune Bullous Skin Diseases (7 papers). Ashio Yoshimura is often cited by papers focused on Renal Diseases and Glomerulopathies (30 papers), Chronic Kidney Disease and Diabetes (20 papers) and Autoimmune Bullous Skin Diseases (7 papers). Ashio Yoshimura collaborates with scholars based in Japan, United States and China. Ashio Yoshimura's co-authors include Charles E. Alpers, Jürgen Floege, P Pritzl, Richard J. Johnson, William G. Couser, Richard J. Johnson, Katherine Gordon, Hiroyuki Iida, Stephen M. Schwartz and Donna M. Lombardi and has published in prestigious journals such as Diabetes, Kidney International and Hypertension.

In The Last Decade

Ashio Yoshimura

68 papers receiving 2.7k citations

Hit Papers

Renal injury from angiotensin II-mediated hypertension. 1992 2026 2003 2014 1992 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashio Yoshimura Japan 23 1.3k 730 528 378 319 75 2.7k
Isao Ebihara Japan 34 1.4k 1.0× 961 1.3× 525 1.0× 344 0.9× 285 0.9× 90 3.3k
Kojiro Nagai Japan 28 808 0.6× 940 1.3× 426 0.8× 301 0.8× 397 1.2× 123 2.8k
Raimund Pichler United States 27 1.3k 0.9× 966 1.3× 228 0.4× 333 0.9× 439 1.4× 45 3.0k
Hoon Young Choi South Korea 24 1.6k 1.2× 651 0.9× 230 0.4× 309 0.8× 425 1.3× 97 2.6k
Harald S. Mackenzie United States 29 932 0.7× 1.0k 1.4× 568 1.1× 522 1.4× 1000 3.1× 51 3.8k
Yoshihiko Ueda Japan 28 659 0.5× 912 1.2× 257 0.5× 521 1.4× 378 1.2× 150 2.9k
U. Helmchen Germany 22 745 0.6× 357 0.5× 476 0.9× 598 1.6× 329 1.0× 65 2.2k
Tracy E. Hunley United States 23 560 0.4× 455 0.6× 446 0.8× 254 0.7× 190 0.6× 45 1.7k
Jan Menne Germany 25 878 0.7× 1.2k 1.7× 399 0.8× 305 0.8× 378 1.2× 68 3.2k
R. Waldherr Germany 32 779 0.6× 1.1k 1.5× 285 0.5× 670 1.8× 336 1.1× 104 3.4k

Countries citing papers authored by Ashio Yoshimura

Since Specialization
Citations

This map shows the geographic impact of Ashio Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashio Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashio Yoshimura more than expected).

Fields of papers citing papers by Ashio Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashio Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashio Yoshimura. The network helps show where Ashio Yoshimura may publish in the future.

Co-authorship network of co-authors of Ashio Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of Ashio Yoshimura. A scholar is included among the top collaborators of Ashio Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashio Yoshimura. Ashio Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otani, Haruhisa, Tadashi Okada, H. Oda, et al.. (2023). Effect of Nonsupplemented Low-Protein Diet on the Initiation of Renal Replacement Therapy in Stage 4 and 5 Chronic Kidney Disease: A Retrospective Multicenter Cohort Study in Japan. Journal of Renal Nutrition. 33(5). 649–656. 4 indexed citations
2.
Piani, Federica, Petter Bjornstad, Claudio Borghi, et al.. (2021). Hyperuricemia and chronic kidney disease: to treat or not to treat. Brazilian Journal of Nephrology. 43(4). 572–579. 25 indexed citations
3.
Sato, Yoshinori, Hiroyasu Tsukaguchi, Koichiro Higasa, et al.. (2021). Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study. BMC Nephrology. 22(1). 230–230. 7 indexed citations
5.
Yoshimura, Ashio, et al.. (2013). Cytokine nephropathy in a patient with fatal Epstein–Barr virus-associated hemophagocytic syndrome. Renal Failure. 35(10). 1445–1448. 3 indexed citations
6.
Sato, Yoshinori, et al.. (2012). Lithium Toxicity Precipitated by Thyrotoxicosis Due to Silent Thyroiditis: Cardiac Arrest, Quadriplegia, and Coma. Thyroid. 23(6). 766–770. 6 indexed citations
7.
Sato, Yoshinori, et al.. (2012). Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy. Internal Medicine. 51(18). 2597–2602. 9 indexed citations
8.
Liu, Yan, et al.. (2012). Losartan preserves glomerular basement membrane anionic charge sites in a rat model of nephropathy. Journal of Nephrology. 26(4). 660–666. 2 indexed citations
9.
Suzuki, Akio, Ashio Yoshimura, Yukio Ozaki, Takashi Kaneko, & Yoshitaka Hara. (2009). Cyclosporin A and Phenytoin Modulate Inflammatory Responses. Journal of Dental Research. 88(12). 1131–1136. 28 indexed citations
10.
Morita, Hiroyuki, et al.. (2009). Portal vein thrombosis in adult-onset Still’s disease: a case report and literature review. Rheumatology International. 29(12). 1515–1518. 8 indexed citations
11.
Ideura, Terukuni, et al.. (2007). Protein Intake of More than 0.5 g/kg BW/Day Is not Effective in Suppressing the Progression of Chronic Renal Failure. Contributions to nephrology. 155. 40–49. 13 indexed citations
12.
Morita, Hiroyuki, Ashio Yoshimura, Kiyoko Inui, et al.. (2005). Heparan Sulfate of Perlecan Is Involved in Glomerular Filtration. Journal of the American Society of Nephrology. 16(6). 1703–1710. 78 indexed citations
13.
Shiiki, Hideo, Takao Saito, Yoshiharu Nishitani, et al.. (2004). Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney International. 65(4). 1400–1407. 128 indexed citations
14.
Montero, Angel, Susumu Uda, Uddhav P. Kelavkar, et al.. (2003). Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis. Journal of Nephrology. 16(5). 682–690. 8 indexed citations
15.
Ideura, Terukuni, et al.. (2003). Effect of nonsupplemented low-protein diet on very late stage CRF. American Journal of Kidney Diseases. 41(3). S31–S34. 9 indexed citations
16.
Sakai, Hideto, Kiyoshi Kurokawa, Takao Saito, et al.. (2002). [Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].. PubMed. 44(8). 751–61. 3 indexed citations
17.
Yoshimura, Ashio, Takashi Nemoto, Kiyoko Inui, et al.. (1999). Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. Kidney International. 56. S84–S87. 38 indexed citations
18.
Ideura, Terukuni, Ashio Yoshimura, Mutsunori Shirai, Takayasu Taira, & Shozo Koshikawa. (1993). Endotoxin-Induced Acute Tubular Necrosis in Cirrhotic Rats. Scandinavian Journal of Urology and Nephrology. 27(4). 433–439. 8 indexed citations
19.
Johnson, Richard J., Charles E. Alpers, Ashio Yoshimura, et al.. (1992). Renal injury from angiotensin II-mediated hypertension.. Hypertension. 19(5). 464–474. 469 indexed citations breakdown →
20.
Yoshimura, Ashio, et al.. (1988). An autopsy case of Weber-Christian with immune complex glomerulonephritis.. PubMed. 30(3). 291–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026